What to Ask at Your First Fertility Consult
SaveWalking into a first fertility appointment with a written list changes the visit. This guide groups the questions that matter: how your infertility is defined, what the evaluation should cover for both partners, which add-ons are evidence-based, how to read the clinic's own numbers, and what the contract and costs really include, so you leave with a plan you understand rather than one you were sold.
Last updated: July 2026
When should you be at a fertility consult at all?
Before the visit, it helps to know whether you meet the usual threshold for evaluation. Clinicians generally define infertility as not conceiving after twelve months of regular unprotected intercourse, or after six months when the woman is 35 or older, and evaluation can reasonably begin sooner when there is a known reason such as irregular cycles or a prior pelvic condition 1Ref 1American Society for Reproductive Medicine (ReproductiveFacts.org) (2024).Defining Infertility (patient education fact sheet).Supports the lay-register definition of infertility (twelve months, or six months if the woman is 35 or older) and when to seek evaluation..
Knowing this lets your first question be simple: given my age and history, does a workup make sense now, and what would change if we waited? Meeting the definition is a reason to evaluate, not a diagnosis in itself, so a good clinic treats the threshold as a starting line rather than a verdict.
It also helps to arrive with your history organized, because the first consult moves faster when the clinic is not reconstructing basics. Note the length and regularity of menstrual cycles, any past pregnancies or losses, prior surgeries or pelvic infections, current medications and supplements, and any relevant family history such as early menopause or genetic conditions. If a partner will be tested, bring their history too. Every fact you supply is a test you may not have to repeat and a month you may not lose. It also helps to jot down your own questions in advance, because the appointment moves quickly and the ones you most want answered are the easiest to forget once you are sitting in the room.
Questions about your diagnosis and the workup
Ask what the clinic will actually test before it recommends treatment. A standard female evaluation proceeds from least invasive to most invasive: a history and physical exam, confirmation that ovulation is happening, ovarian-reserve testing, and a check that the fallopian tubes are open, usually with an HSG 2Ref 2Practice Committee of ASRM (2021).Fertility evaluation of infertile women: a committee opinion.Supports what a standard female fertility workup includes and its least-invasive-first order: history and exam, ovulation assessment, ovarian-reserve testing, and tubal-patency testing by HSG.. Good questions here are 'what will you test,' 'in what order,' and 'what would each result change about the plan?'
It is fair to ask how long the workup will take and what would speed it or slow it, since some tests are timed to specific days of a menstrual cycle. Ask, too, what the clinic will do if the workup finds nothing, because unexplained infertility is a real and common result, not a dead end. A clinic that has a thoughtful answer for the normal-results scenario is one that treats diagnosis as more than a formality. Ask also whether any recent test results you already have can be reused, since repeating bloodwork or imaging you had done elsewhere wastes both time and money.
A workup exists to find a cause, and the cause should drive the treatment. Be cautious about a clinic that recommends a specific, expensive pathway before the evaluation is complete.
A treatment plan offered before the workup is finished is a plan worth questioning.
Are you evaluating both of us?
If there is a partner who produces sperm, ask whether that partner is being evaluated in parallel, not months after treatment on you has begun. Joint guidance is explicit that both partners should be assessed concurrently, that semen analysis is a core early test, and that male-factor infertility can be the first sign of a serious underlying condition such as a testicular tumor, a pituitary problem, or a hormone disorder 3Ref 3American Urological Association / American Society for Reproductive Medicine (2020).Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I.Supports that both partners should be evaluated concurrently, that semen analysis is a core early test, and that male-factor infertility can signal a serious underlying condition..
Roughly half of the picture in a couple's infertility can involve the male partner, so a clinic that treats the male evaluation as an afterthought is working with half a diagnosis. Ask practical follow-ups: when will the semen analysis be scheduled, does the clinic want more than one sample given that results can vary, and who interprets it.
If a result is abnormal, ask whether a referral to a specialist in male reproduction is part of the plan. The point is not to assign blame but to make sure both halves of the couple are worked up with equal seriousness, because a treatment aimed only at one partner can miss the actual cause. If both of you are being tested, ask when each result comes back and who will walk you through them together, so no finding sits unexplained.
Which parts of this plan actually have evidence?
When a clinic proposes 'add-ons,' extra procedures and tests layered onto a standard cycle, ask which have real evidence and which are optional extras. The UK regulator rates common add-ons on a five-tier, color-coded scale, and most fall where the evidence of benefit is weak or absent, with a few carrying possible harm 4Ref 4Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.Supports that most marketed IVF add-ons lack good evidence of benefit and some may cause harm, per the HFEA's five-tier color-coded ratings.. Preimplantation genetic testing for aneuploidy, one of the most-sold add-ons, has not been shown to raise success for the general IVF population in recent multicenter trials 5Ref 5Practice Committees of ASRM and SART (2024).The use of preimplantation genetic testing for aneuploidy: a committee opinion.Supports that the value of PGT-A as a routine screen for all IVF patients has not been demonstrated, and that recent multicenter trials found similar overall outcomes with versus without it..
an add-on is an extra test or procedure sold on top of a standard IVF cycle.
A useful frame is to ask the clinic to divide its proposal into two columns: what is standard, evidence-based care, and what is an optional extra. Then ask, for each extra, what it costs and what a good-quality study says it achieves. Add-ons are not automatically bad, and a few have specific, legitimate indications; the problem is only when an unproven extra is presented as essential 4Ref 4Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.Supports that most marketed IVF add-ons lack good evidence of benefit and some may cause harm, per the HFEA's five-tier color-coded ratings..
A fair clinic will separate what is standard from what is upsell, and will be comfortable telling you which parts you could skip. One that presents every add-on as non-negotiable, or implies you are lowering your chances by declining, is selling rather than advising. A fair question is simply whether, if this extra were free, the clinic would still recommend it, and if not, why you are paying for it; the answer separates a genuinely indicated extra from a default upsell.
How do you report your success rates?
Ask the clinic to show its outcomes for patients like you, and to name the denominator. SART reports results by patient age band and by cycle, with per-retrieval, per-transfer, per-new-patient, and cumulative groupings 6Ref 6Society for Assisted Reproductive Technology (SART) (2024).National Summary Report (SART CORS Online).Supports that SART reports outcomes by patient age band and by cycle, with per-retrieval, per-transfer, per-new-patient, and cumulative groupings a patient can ask a clinic to quote., so a fair answer sounds like 'here is our live-birth rate per intended retrieval for your age band,' not a single glossy percentage.
It is reasonable to ask how the clinic's results compare with national figures for your age band, and to ask what its single-embryo-transfer rate and multiple-birth rate are, since a high multiple rate can inflate a per-transfer number while adding pregnancy risk. You are not being adversarial by asking; you are asking the clinic to show its work, and how it responds, openly or defensively, tells you almost as much as the numbers do.
When you are comparing clinics, insist on the same denominator and the same age band each time, or you are comparing nothing, which is exactly how clinic success rates mislead. It is reasonable to research a fertility clinic near you against the public reports before the visit, then use the consult to ask why its numbers look the way they do. You can also ask the clinic to hand you its own most recent report rather than a curated summary slide, and to point out where its results sit relative to the national figures for your bracket.
What will this actually cost, and what does the contract say?
Ask for an itemized estimate of a full cycle and of everything that sits outside the base price: monitoring visits, anesthesia, medications, genetic testing, and annual storage. Then ask how any multi-cycle package or refund program defines success and what it excludes. Costs in fertility care are rarely a single number, and the gap between the advertised price and the all-in price can be large.
Ask specifically what a cancelled cycle costs, what storage costs each year, and how long any deposit is held, because the base fee rarely includes everything. These smaller line items compound quietly and can change your plan.
Reading a fertility treatment contract closely, before you sign, is where informed consent actually happens. The document, not the brochure, governs what you are buying, including what a refund program keeps if a cycle fails. If a term is unclear, ask for it in writing rather than accepting a verbal reassurance. Ask, too, whether the estimate is a firm quote or an average, and whether it can change once your workup is complete, because a number that sounds precise on day one may not survive the diagnosis.
Logistics, monitoring, and a second opinion
Finally, ask the practical questions that shape months of your life: who you will actually see at each visit, how monitoring appointments are scheduled, how the clinic communicates results, and what happens after hours. If you are weighing a virtual-first or telehealth fertility program, ask exactly which parts of a cycle happen locally versus remotely, because monitoring ultrasounds, bloodwork, retrievals, and transfers are physical procedures that must happen somewhere near you.
And remember that asking for a fertility second opinion is routine, not rude. A clinic confident in its plan will not resist one, and a fresh set of eyes is especially worth it before an expensive cycle or after one that did not work.
If a plan feels rushed, or a clinic pressures you to commit or to add expensive extras on the spot, treat that pressure as information. The best consults end with you holding a written summary of the plan, the costs, and the next steps, not just a good feeling. The goal of the whole visit is to leave with a plan you understand and can question, not one you simply agreed to.
Answers that should give you pause
A few responses are worth noticing as you go. A guaranteed outcome, a refusal to share results in your own age band, a treatment plan proposed before the workup is finished, or pressure to decide immediately are all signals to slow down. So is a clinic that cannot explain, in plain language, why it is recommending a particular add-on, or that answers a direct question about cost with vagueness.
None of these means a clinic is bad, and a warm, confident practice can still be the right one. But each is a reason to ask another question, to take the plan home and read it, or to seek a second opinion before you sign anything. The through-line of every question in this guide is the same: you are trying to understand the plan well enough to agree to it, not to be talked into it. Give yourself permission to leave without deciding: a reputable clinic expects patients to take a plan home, read it, and return with more questions, and no good treatment decision requires being made in the room that day.
Common questions
Related
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When fertility treatment becomes urgent
- —Severe abdominal bloating and pain, rapid weight gain over a day or two, nausea with vomiting, shortness of breath, or urinating much less than usual after an egg retrieval, which can signal ovarian hyperstimulation syndrome
- —Sharp or one-sided pelvic pain, shoulder-tip pain, dizziness or fainting, or heavy bleeding after a positive pregnancy test, which can signal an ectopic pregnancy
- —Fever with pelvic pain, or heavy vaginal bleeding, after a retrieval or transfer procedure
- —Calf swelling and pain, or sudden chest pain and breathlessness, since clot risk is higher during ovarian stimulation
Ovarian hyperstimulation syndrome, ectopic pregnancy, and blood clots are medical emergencies: call 911 or go to the nearest emergency department for severe abdominal pain, breathlessness, fainting, or heavy bleeding, and call your fertility clinic's 24-hour line for anything that worries you.
This article offers questions to bring to a fertility consult. It is educational and is not a substitute for personalized advice from a licensed clinician who knows your history.
References
- 1.American Society for Reproductive Medicine (ReproductiveFacts.org) (2024). Defining Infertility (patient education fact sheet). ASRM ReproductiveFacts.org. linkSupports the lay-register definition of infertility (twelve months, or six months if the woman is 35 or older) and when to seek evaluation.
- 2.Practice Committee of ASRM (2021). Fertility evaluation of infertile women: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkSupports what a standard female fertility workup includes and its least-invasive-first order: history and exam, ovulation assessment, ovarian-reserve testing, and tubal-patency testing by HSG.
- 3.American Urological Association / American Society for Reproductive Medicine (2020). Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. AUA/ASRM (Fertility and Sterility; Journal of Urology). PMID 33295257 ✓Supports that both partners should be evaluated concurrently, that semen analysis is a core early test, and that male-factor infertility can signal a serious underlying condition.
- 4.Human Fertilisation and Embryology Authority (2024). Treatment add-ons with limited evidence. Human Fertilisation and Embryology Authority (UK). link ✓Supports that most marketed IVF add-ons lack good evidence of benefit and some may cause harm, per the HFEA's five-tier color-coded ratings.
- 5.Practice Committees of ASRM and SART (2024). The use of preimplantation genetic testing for aneuploidy: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). PMID 38762806 ✓Supports that the value of PGT-A as a routine screen for all IVF patients has not been demonstrated, and that recent multicenter trials found similar overall outcomes with versus without it.
- 6.Society for Assisted Reproductive Technology (SART) (2024). National Summary Report (SART CORS Online). Society for Assisted Reproductive Technology. link ✓Supports that SART reports outcomes by patient age band and by cycle, with per-retrieval, per-transfer, per-new-patient, and cumulative groupings a patient can ask a clinic to quote.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy